Reuters logo
BRIEF-Baxter and Scinopharm announce partnership for generic oncology injectables
February 28, 2017 / 1:31 PM / 9 months ago

BRIEF-Baxter and Scinopharm announce partnership for generic oncology injectables

Feb 28 (Reuters) - Baxter International Inc

* Baxter and Scinopharm announce exclusive strategic partnership for generic oncology injectables

* Baxter International Inc - under terms of partnership, Baxter and Scinopharm will collaborate on product development and manufacturing

* Baxter International Inc - Baxter will hold commercialization rights, with products included in arrangement expected to launch beginning in 2020 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below